Trivest Advisors Ltd Sells 132,012 Shares of Zepp Health Corporation Sponsored ADR $ZEPP

Trivest Advisors Ltd decreased its holdings in shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) by 81.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,892 shares of the company’s stock after selling 132,012 shares during the quarter. Zepp Health accounts for approximately 0.0% of Trivest Advisors Ltd’s investment portfolio, making the stock its 29th largest position. Trivest Advisors Ltd’s holdings in Zepp Health were worth $369,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Monolith Management Ltd acquired a new stake in shares of Zepp Health in the 4th quarter valued at approximately $3,601,000. Harvest Fund Management Co. Ltd increased its position in Zepp Health by 6.7% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock worth $1,207,000 after purchasing an additional 2,800 shares in the last quarter. Themes Management Co LLC acquired a new position in Zepp Health during the 4th quarter worth approximately $489,000. Capstone Capital Management Ltd bought a new position in Zepp Health in the 4th quarter valued at approximately $298,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Zepp Health in the 4th quarter valued at approximately $543,000. Institutional investors own 52.61% of the company’s stock.

Zepp Health Stock Performance

NYSE ZEPP opened at $5.42 on Monday. The company has a market capitalization of $79.57 million, a price-to-earnings ratio of -2.15 and a beta of 1.83. The company has a quick ratio of 0.67, a current ratio of 0.88 and a debt-to-equity ratio of 0.21. Zepp Health Corporation Sponsored ADR has a twelve month low of $3.85 and a twelve month high of $61.85. The stock has a fifty day simple moving average of $6.54 and a 200 day simple moving average of $14.69.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Wall Street Zen raised shares of Zepp Health from a “sell” rating to a “hold” rating in a research note on Saturday. Fundamental Research set a $56.28 price target on Zepp Health and gave the company a “buy” rating in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $56.28.

Insider Activity at Zepp Health

In other news, CFO Cheng Deng sold 9,836 shares of the stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $4.61, for a total value of $45,343.96. Following the completion of the sale, the chief financial officer owned 114,539 shares of the company’s stock, valued at approximately $528,024.79. This represents a 7.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 36.00% of the company’s stock.

Zepp Health Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.